Gene therapy makers wonder if they can make a profit in Europe. Patients fear being left behind — again

Also: A geriatrician makes the case against maximum age limits for politicians, and the FDA calls for meth and cocaine addiction treatment.

October 4, 2023 Check out STAT+

Sponsored By

Eros Dervishi for STAT STAT+ | Gene therapy makers wonder if they can make a profit in Europe. Patients fear being left behind — again Life-changing treatments are colliding with cost-conscious national health systems empowered to negotiate prices. By Andrew Joseph STAT+ | FDA cites Fresenius Kabi for contamination problems that CDC linked to deadly sepsis cases The episode was traced to a Fresenius Kabi manufacturing facility in Puerto Rico that previously received an FDA warning. By Ed Silverman STAT+ | To prevent amputation in patients with severe vascular disease, a device turns veins into arteries The FDA approved a new surgical device for patients with severe vascular disease and no other treatment options. Will it save legs? By Lizzy Lawrence Claudio Bresciani/TT News Agency via AP 2023 Nobel Prize in chemistry: Trio win for quantum dots discoveries that revolutionized nanotechnology The prize was awarded to three scientists for their work with quantum dots, tiny particles that have fueled innovations in nanotechnology. By Andrew Joseph Opinion: The case against age limits for politicians A geriatrician explains why the idea of maximum age for politicians won't help America — and might hurt us. By Anna Chodos STAT+ | Colombia set to issue a compulsory license for an HIV medicine sold by GSK's ViiV The move underscores ongoing friction between the pharmaceutical industry and cash-strapped governments around the world. By Ed Silverman Spencer Platt/Getty Images FDA calls for treatments for meth and cocaine addiction Food and Drug Administration seeks to spur drug manufacturers to develop treatments for addiction to meth, cocaine, or prescription stimulants. By Lev Facher

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser